second

North Texas Innovation Alliance And Partners Announce Second Annual SCEWC Smart Cities Global Startup Challenge

2025 Pitching Challenge Encourages International Innovation and Economic Development DALLAS, Aug. 19, 2025 /PRNewswire/ -- North Texas Innovation Alliance (NTXIA),…

5 months ago

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

    - Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial - Expanded global IP protection by securing…

5 months ago

CNRC Reports Q2 2025 Financials Period Ending June 30, 2025; Provides Shareholder Update on Portfolio Companies

CHARLESTON, W.Va., Aug. 15, 2025 /PRNewswire/ -- Surya Oil & Gas Corp. (OTCID: CNRC), ( "SOGC" or the "Company" ) formerly…

5 months ago

CisionOne Wins “Best Media Monitoring Solution” for Second Consecutive Year at 2025 MarTech Breakthrough Awards

CHICAGO, Aug. 14, 2025 /PRNewswire/ -- Cision, a global leader in consumer and media intelligence, today announced that CisionOne has…

5 months ago

Parallels Named a Visionary in 2025 Gartner Magic Quadrant for Desktop as a Service for Second Year in a Row

AUSTIN, Texas, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Parallels, a global leader in virtualization and end-user computing (EUC) solutions, today…

5 months ago

Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call

August 13, 2025 11:45 ET  | Source: Milestone Scientific, Inc. ROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific…

5 months ago

GameChange Solar Rises to Third Globally and Second in U.S. Solar Tracker Market

NORWALK, Conn., Aug. 12, 2025 /PRNewswire/ -- GameChange Solar has solidified its position as one of the world's leading solar…

5 months ago

slice brings UPI-powered bank branch and ATM to Gurugram

slice SFB expands physical footprint with the launch of a UPI-first bank branch in Gurugram GURUGRAM, India, Aug. 13, 2025…

5 months ago

Satellogic Reports Second Quarter Financial Results

27% Increase in Revenue to $4.4 million Coupled with 41% Decrease in Operating Costs and Expenses in 2Q 2025 Poised…

5 months ago

Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

Announced first patient dosed in the Phase 2b placebo-controlled portion of the EP-104GI RESOLVE trial with topline data expected in…

5 months ago